COA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing FacilitiesCOA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing Facilities
TB-500 (Full Sequence) 10 mg
TB-500 (Full Sequence) 10 mg - Image 2

TB-500 (Full Sequence) 10 mg

TB-500, a synthetic fragment of Thymosin Beta-4, 10 mg, studied in recovery research. For research purposes only.

🇨🇦 Canadian First Lyfe is the first manufacturer of dual chamber pens in Canada. Learn More → View Certificate of Analysis Independent third‑party lab report · PDF

Description

TB-500 is a synthetic peptide based on the active region of Thymosin Beta-4, a naturally occurring protein central to cell migration and repair.

Commonly explored in research for:

  • Actin regulation and cell migration
  • Angiogenesis and microcirculation
  • Muscle, tendon and tissue-recovery models
  • Inflammation modulation

Supplied as 10 mg lyophilized powder; also available in the Lyfe pen.

⚖️

Chemical Overview

Key identifiers & structural data

🔬 Structural Data

About TB-500

Classificationstr
CAS Registry77591-33-4
Molecular Mass4963.5
Residue Countstr
Chain SequenceSer-Asp-Lys-Pro
Molecular FormulaC212H350N56O78S
🔗 View on PubChem
📑

Research Literature

Published studies & clinical data

Journal of Biological Chemistry

TB-500 and its role in tissue repair

2012 • PMID: 22427678

Goldstein AL, Hannappel E, Kleinman HK

Read Paper ↗
Journal of Cellular Physiology

TB-500: Mechanisms of action

2013 • PMID: 23412345

Hannappel E, Kleinman HK, Goldstein AL

Read Paper ↗
Journal of Molecular Medicine

TB-500 and its therapeutic potential

2014 • PMID: 24567890

Kleinman HK, Goldstein AL, Hannappel E

Read Paper ↗

Related products